HomeORCHPHARMA • NSE
add
Orchid Pharma Ltd
Previous close
₹786.00
Day range
₹777.10 - ₹794.00
Year range
₹603.80 - ₹1,997.40
Market cap
39.75B INR
Avg Volume
118.24K
P/E ratio
76.03
Dividend yield
-
Primary exchange
NSE
Market news
Financials
Income Statement
Revenue
Net income
| (INR) | Sep 2025info | Y/Y change |
|---|---|---|
Revenue | 1.94B | -13.10% |
Operating expense | 713.95M | 2.25% |
Net income | -57.24M | -121.01% |
Net profit margin | -2.96 | -124.20% |
Earnings per share | -1.13 | -121.04% |
EBITDA | -15.99M | -105.29% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (INR) | Sep 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 1.49B | -39.11% |
Total assets | 17.22B | 5.31% |
Total liabilities | 4.48B | 9.08% |
Total equity | 12.74B | — |
Shares outstanding | 50.65M | — |
Price to book | 3.13 | — |
Return on assets | — | — |
Return on capital | -1.73% | — |
Cash Flow
Net change in cash
| (INR) | Sep 2025info | Y/Y change |
|---|---|---|
Net income | -57.24M | -121.01% |
Cash from operations | — | — |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | — | — |
Free cash flow | — | — |
About
Orchid Pharma Limited is an Indian pharmaceutical company based in Chennai, founded on 1 July 1992. As of 2024, it was among the top fortune 500 Indian companies by market capitalization. Orchid Pharma is the only pharma company in India to have discovered a New Drug Enmetazobactam which is now approved in United States, Europe and India. Wikipedia
Founded
1992
Website
Employees
736
